PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Profitability reveals how effectively the business turns revenues into profits. Higher and improving margins or returns on capital suggest a durable competitive advantage, supporting a stronger intrinsic valuation.
4.62%
ROE exceeding 1.5x Healthcare median of 0.44%. Joel Greenblatt would check if high returns reflect a sustainable advantage.
1.76%
Positive ROA while Healthcare median is negative. Philip Fisher would see if the firm has a stronger model than peers.
5.43%
ROCE exceeding 1.5x Healthcare median of 0.01%. Joel Greenblatt would look for a high return on incremental capital.
17.73%
Gross margin below 50% of Healthcare median of 44.72%. Jim Chanos would suspect flawed products or pricing.
3.34%
Margin of 3.34% while Healthcare median is zero. Walter Schloss would see if moderate profitability can be leveraged further.
2.52%
Net margin of 2.52% while Healthcare is zero. Walter Schloss would examine if modest profitability can expand.